Replies to post #118057 on Cytodyn Inc (CYDY)

[All-Bidness]

They NEED to focus on completing enrollment for CD12. We're just over 50% there 210 out of 390, chances are the DMSC will not halt the trial but will allow to continue. We shouldn't be starting other trails ie. NASH and "long haulers" until CD12 is complete.